PRILOCID 20 CAP, manufactured by Bluepill Express under the Dr Precision brand, is an advanced proton pump inhibitor capsule containing 20 mg of Omeprazole. Designed specifically to inhibit gastric acid secretion, PRILOCID 20 CAP effectively manages and treats various acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, Helicobacter pylori-associated ulcers, and Zollinger-Ellison syndrome. Utilizing a delayed-release, enteric-coated formulation, this capsule ensures the active ingredient bypasses stomach acidity to be absorbed in the small intestine, enhancing bioavailability and therapeutic efficacy. Its long-lasting acid suppression effect provides consistent relief from symptoms like heartburn, acid regurgitation, and esophageal erosions while promoting ulcer healing and preventing gastrointestinal complications related to NSAID or corticosteroid use. The formulation aligns with circadian acid secretion patterns when administered once daily before meals, optimizing patient outcomes. Produced in WHO-GMP certified facilities, PRILOCID 20 CAP offers clinical precision, reliable dosing, and a safety profile suitable for both acute and long-term management of acid-peptic disorders. It is an essential pharmaceutical option for healthcare providers seeking an effective and well-tolerated PPI for their patients’ gastrointestinal care protocols.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Omeprazole 20 mg |
| Pharmaceutical Form | Delayed-release enteric-coated capsule |
| Primary Use | Treatment of acid-related gastrointestinal disorders |
| Key Indications | GERD, peptic ulcers, Zollinger-Ellison syndrome, Helicobacter pylori-associated ulcers |
| Manufacturing Standard | WHO-GMP certified facility by Bluepill Express |
| Brand | Dr Precision |
| Mechanism of Action | Irreversible inhibition of H+/K+ ATPase enzyme in gastric parietal cells |
| Dosage Recommendation | Typically once daily before meals; adjustable per clinical needs |
| Bioavailability | Optimized via delayed-release formulation and enteric coating |
| Safety Profile | Well-tolerated with minor common side effects; rare serious adverse effects possible on prolonged use |
| Attributes | Description |
|---|---|
| Dose Strength | 20 mg Omeprazole per capsule |
| Capsule Type | Cap, delayed-release |
| Packaging | Available in blister packs (varied quantities) |
| Shelf Life | As per regulatory standards, typically 2 years |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Therapeutic Category | Proton Pump Inhibitor (PPI) |
| Regulatory Compliance | Manufactured under GMP standards, WHO-GMP certified |
| Indicated Patient Groups | Adults requiring gastric acid suppression therapy |
| Administration Route | Oral |
| Pharmacokinetics | Delayed-release granules for intestinal absorption; duration up to 24 hours |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
PRILOCID 20 CAP uses delayed-release enteric-coated granules to protect Omeprazole from degradation in the acidic stomach environment, allowing absorption in the small intestine, thereby improving bioavailability and therapeutic effect.
Yes, PRILOCID 20 CAP is indicated for managing Zollinger-Ellison syndrome, offering sustained acid suppression; however, dosing may require adjustment and medical supervision during long-term therapy.
Yes, PRILOCID 20 CAP is commonly prescribed in combination with specific antibiotics as part of Helicobacter pylori eradication regimens to enhance ulcer healing.
In severe erosive esophagitis cases, higher or divided doses of PRILOCID 20 CAP may be necessary, and such dosing adjustments should be carried out under healthcare provider supervision.
Prolonged use of PRILOCID 20 CAP can rarely lead to vitamin B12 deficiency or hypomagnesemia; hence, monitoring is advised in long-term treatments.
Country Of Origin: India
PRILOCID 20 CAP contains Omeprazole 20 mg, a proton pump inhibitor (PPI) used to treat acid-related gastrointestinal disorders. It is widely prescribed for conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Manufactured by Bluepill Express in WHO-GMP certified facilities, this capsule offers consistent acid suppression with excellent therapeutic tolerability.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
PRILOCID 20 CAP is a highly effective formulation of Omeprazole 20 mg, a widely recognized proton pump inhibitor used in the management and treatment of various acid-peptic disorders. It is designed to reduce gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the surface of gastric parietal cells. This targeted action makes Omeprazole particularly useful in treating gastrointestinal conditions where acid control is crucial.
The therapeutic efficacy of PRILOCID 20 CAP lies in its ability to provide long-lasting acid suppression, thereby relieving symptoms associated with gastroesophageal reflux disease (GERD), healing erosive esophagitis, and promoting ulcer recovery. It is also indicated in cases of Helicobacter pylori-associated ulcers, where it is used in combination with appropriate antibiotics as part of eradication regimens. Additionally, PRILOCID 20 CAP plays a vital role in managing Zollinger-Ellison syndrome, a condition characterized by excessive gastric acid production.
Each PRILOCID 20 capsule delivers a consistent dose of Omeprazole in a delayed-release formulation to ensure the drug bypasses the acidic environment of the stomach and is absorbed in the small intestine. This mechanism improves bioavailability while protecting the active ingredient from degradation. The enteric-coated granules ensure optimal delivery of the drug at the desired site of action, ensuring a prolonged and consistent suppression of gastric acid for up to 24 hours.
PRILOCID 20 CAP is generally taken once daily before meals, preferably in the morning, to align with the circadian rhythm of gastric acid secretion. In cases of severe erosive esophagitis or Zollinger-Ellison syndrome, higher or divided doses may be administered under medical supervision. The formulation is well-tolerated in most patients and has a favorable safety profile. Common side effects include headache, nausea, abdominal discomfort, or constipation, while rare but serious adverse reactions such as vitamin B12 deficiency or hypomagnesemia may occur with prolonged use.
Omeprazole’s mechanism of action makes it especially effective in providing symptom relief from acid reflux, heartburn, and regurgitation. Moreover, its ulcer-healing properties make it a valuable therapeutic option in NSAID-induced gastric ulcers or stress-related mucosal damage in critically ill patients. PRILOCID 20 CAP has also demonstrated benefit as a prophylactic agent in patients at risk of gastrointestinal bleeding due to long-term NSAID or corticosteroid therapy.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
